Drug profile

The FDA adverse-event record for Anti-Inflamatory

24 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Anti-Inflamatory. See the species affected, top reactions, and outcomes below.

24
adverse-event reports
41.7%
death-coded share
Dog
most-reported species
9
Lethargy (see also Central nervous system depression in 'Neurological') - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
24
Total Reports
10
Deaths Reported
41.7%
Death Rate

Active Ingredients

Anti-Inflamatory

Administration Routes

UnknownOralTopical

Species Affected

Dog 17
Cat 6
Rabbit 1

Most Affected Breeds

Retriever - Labrador 3
Domestic Shorthair 2
Domestic Longhair 2
Chihuahua 2
American Shorthair 1
Dog (unknown) 1
Shepherd (unspecified) 1
American Curl Shorthair 1
Retriever - Golden 1
Terrier - Jack Russell 1

Most Reported Reactions

Lethargy (see also Central nervous system depression in 'Neurological') 9
Anorexia 7
Death 6
Vomiting 5
Fever 5
Death by euthanasia 4
Shaking 3
Seizure NOS 2
Leucocytosis NOS 2
Pancreas disorder 2
Lameness 2
Oedema NOS (see other SOCs for specific oedemas) 2

Outcome Breakdown

Ongoing
10 (41.7%)
Died
7 (29.2%)
Euthanized
3 (12.5%)
Outcome Unknown
3 (12.5%)
Recovered/Normal
1 (4.2%)

Anti-Inflamatory Adverse Event Insights

24 reports name Anti-Inflamatory; 10 recorded a death outcome (41.7% of reported events, not a population-level mortality rate). Active ingredient: Anti-Inflamatory. Administration routes: Unknown, Oral, Topical.

By species: Dog (17 reports), Cat (6 reports), Rabbit (1 reports). By breed: Retriever - Labrador (3), Domestic Shorthair (2), Domestic Longhair (2).

Leading clinical signs: Lethargy (see also Central nervous system depression in 'Neurological') (9), Anorexia (7), Death (6), Vomiting (5). Outcome, 24 coded reports: Ongoing leads at 41.7%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.